Related Experiment Video
Updated: Oct 14, 2025

Group Synchronization During Collaborative Drawing Using Functional Near-Infrared Spectroscopy
Published on: August 5, 2022
DCTclock: Clinically-Interpretable and Automated Artificial Intelligence Analysis of Drawing Behavior for Capturing
William Souillard-Mandar1,2,3, Dana Penney1,4, Braydon Schaible1
1Digital Cognition Technologies, Boston, MA, United States.
This article introduces DCTclock, an automated tool that analyzes how people draw clocks to detect early signs of cognitive decline. By using digital pens to track drawing movements, the system identifies subtle patterns that traditional paper tests often miss. The researchers validated this approach using data from over 1,800 individuals, demonstrating its effectiveness in identifying early impairment and tracking Alzheimer's disease progression. This technology provides a faster, more sensitive way to assess brain health in clinical and research settings.
Area of Science:
- Neurological diagnostics and DCTclock digital biomarkers
- Artificial intelligence in clinical medicine
Background:
Measuring cognitive decline remains a persistent hurdle for clinicians managing neurodegenerative conditions like Alzheimer's disease. Traditional paper-based assessments often lack the sensitivity required to detect subtle, early-stage neurological changes. While these standard tools provide a baseline, they frequently fail to capture the nuanced behavioral data inherent in complex tasks. Recent technological progress has introduced connected devices capable of recording precise, time-stamped information during patient interactions. Artificial intelligence now offers a pathway to transform these raw data streams into actionable clinical insights. This gap motivated the development of automated systems that move beyond simple task completion metrics. No prior work had resolved how to integrate digital input with machine learning to refine established cognitive screening methods. That uncertainty drove the creation of a framework designed to improve diagnostic precision through high-resolution behavioral analysis.
Purpose Of The Study:
The aim of this research was to develop an automated tool for measuring cognitive change and brain health. The authors sought to address the limitations of traditional, manual cognitive status tests. They specifically focused on enhancing the sensitivity of the Clock Drawing Test through digital technology. The team intended to create a system capable of capturing nuanced behavioral data during drawing tasks. This motivation stemmed from the need for faster, cheaper, and non-intrusive diagnostic tools for clinical use. They also aimed to provide a robust framework for generating digital biomarkers for clinical trials. The researchers addressed the challenge of detecting early-stage neurological conditions like Alzheimer's disease. By integrating machine learning, they worked to improve the accuracy of cognitive assessments beyond simple task completion.
Main Methods:
Review Approach involved developing an automated analysis system based on the traditional Clock Drawing Test. The researchers integrated a digital input device to capture precise, time-stamped drawing coordinates from participants. They applied machine learning algorithms to interpret these behavioral data points during the task. Validation occurred using a large cohort of 1,833 individuals with varying neurological health statuses. The team compared their automated results against established manual scoring systems for clock drawing. They also benchmarked the system performance against the Mini-Mental Status Examination. This comparative analysis allowed for the evaluation of sensitivity in detecting early cognitive impairment. The study design focused on creating a robust framework for generating digital biomarkers applicable in clinical environments.
Main Results:
Key Findings From the Literature indicate that the automated system significantly improves the detection of early cognitive impairment. The researchers validated this tool using a dataset of 1,833 participants, including both cognitively unimpaired and clinically diagnosed individuals. Their analysis showed that the system effectively characterizes patients along the Alzheimer's disease trajectory. The tool outperformed existing manual clock scoring systems in sensitivity. It also demonstrated superior diagnostic capabilities compared to the Mini-Mental Status Examination. By capturing nuanced drawing behaviors, the system identified performance patterns that traditional tests often miss. The results confirm that this digital approach provides a reliable method for assessing neurological function. These findings establish a high-sensitivity framework for future clinical and research applications.
Conclusions:
The authors propose that their automated system serves as a robust framework for generating digital biomarkers. Synthesis and Implications reveal that this approach enhances the detection of early cognitive impairment compared to traditional scoring methods. The researchers demonstrate that their tool effectively characterizes patients across the Alzheimer's disease trajectory. This system provides a more sensitive alternative to lengthier, conventional cognitive examinations. The findings suggest that capturing time-stamped drawing coordinates offers superior insights into neurological function. By leveraging machine learning, the platform identifies performance nuances that standard manual assessments overlook. The study highlights the potential for deploying such technology within both clinical practice and research trials. These results underscore the value of integrating digital input devices to improve the accuracy of cognitive health monitoring.
Frequently Asked Questions
The researchers propose that the system detects cognitive impairment by analyzing time-stamped drawing coordinates. Unlike traditional scoring, this machine learning approach captures subtle behavioral nuances during the clock drawing task, allowing for more sensitive identification of early neurological decline than standard manual methods.
The team utilized a digital input device to record precise drawing movements. This hardware captures high-resolution temporal and spatial data, which the machine learning algorithm then processes to evaluate performance beyond simple completion of the drawing task.
The authors state that capturing time-stamped coordinates is necessary to distinguish between healthy individuals and those with neurological conditions. This temporal data provides the granular detail required to characterize performance patterns that are otherwise invisible in static, paper-based assessments.
The researchers employed a dataset of 1,833 participants, including both cognitively unimpaired individuals and those with clinical diagnoses. This diverse group allowed the team to validate the tool across various neurological conditions and establish its effectiveness in tracking disease progression.
The team measured performance by benchmarking their system against existing clock scoring methods and the Mini-Mental Status Examination. This comparison demonstrated that their digital approach offers significant improvements in sensitivity for detecting early impairment compared to these established, lengthier tests.
The researchers propose that this framework offers a scalable model for creating digital biomarkers. They imply that such tools could be deployed rapidly and non-intrusively in clinical settings to improve the efficiency of monitoring brain health over time.

